Vasopressin enhances a calcium current in human ACTH-secreting pituitary adenoma cells

P. Mollard, P. Vacher, Michael A Rogawski, B. Dufy

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Arginine vasopressin (AVP) is a potent secretagogue for adrenocorticotropin (ACTH) release from normal corticotropes and from ACTH-secreting pituitary adenoma cells. To explore the mechanism underlying this action, we investigated the effects of AVP on Ca2+-dependent action potentials and Ca2+ currents in cultured human ACTH-contaning pituitary tumor cells (hACTH adenoma cells). Pituitary adenoma fragments removed at surgery from two patients with Cushing's disease were dispersed, and the isolated cells were grown in monolayer culture. Most of the cells showed ACTH immunoreactivity that persisted even after as much as 2 months in culture. Current clamp and voltage clamp recordings were carried out using the patch-clamp technique in the whole cell configuration. AVP produced an increase in the amplitude and duration of action potentials in these cells, and substantially enhanced the transient after-hyperpolarization after each spike. Under voltage clamp, hACTH adenoma cells showed two Ca2+ current components: a low-threshold, rapidly inactivating (T-type) current; and a higher threshold, slowly inactivating (L-type) current. AVP markedly increased the amplitude of the L-type current without affecting the T-type current. These data suggest that AVP may enhance Ca2+ entry associated with action potentials by potentiating the activity of L-type Ca2+ channels. The resulting rise in cytosolic free Ca2+ may be a key link in the process by which AVP stimulates ACTH release in the pituitary.

Original languageEnglish (US)
Pages (from-to)2907-2912
Number of pages6
JournalFASEB Journal
Volume2
Issue number13
StatePublished - 1988
Externally publishedYes

Fingerprint

ACTH-Secreting Pituitary Adenoma
vasopressin
Arginine Vasopressin
arginine vasopressin
adenoma
corticotropin
Vasopressins
Adrenocorticotropic Hormone
Clamping devices
Calcium
calcium
action potentials
cells
Action Potentials
Pituitary Neoplasms
Adenoma
Cushing syndrome
Electric potential
patch-clamp technique
Pituitary ACTH Hypersecretion

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Vasopressin enhances a calcium current in human ACTH-secreting pituitary adenoma cells. / Mollard, P.; Vacher, P.; Rogawski, Michael A; Dufy, B.

In: FASEB Journal, Vol. 2, No. 13, 1988, p. 2907-2912.

Research output: Contribution to journalArticle

Mollard, P. ; Vacher, P. ; Rogawski, Michael A ; Dufy, B. / Vasopressin enhances a calcium current in human ACTH-secreting pituitary adenoma cells. In: FASEB Journal. 1988 ; Vol. 2, No. 13. pp. 2907-2912.
@article{4e791c7d054b41b885adfe7fc693a270,
title = "Vasopressin enhances a calcium current in human ACTH-secreting pituitary adenoma cells",
abstract = "Arginine vasopressin (AVP) is a potent secretagogue for adrenocorticotropin (ACTH) release from normal corticotropes and from ACTH-secreting pituitary adenoma cells. To explore the mechanism underlying this action, we investigated the effects of AVP on Ca2+-dependent action potentials and Ca2+ currents in cultured human ACTH-contaning pituitary tumor cells (hACTH adenoma cells). Pituitary adenoma fragments removed at surgery from two patients with Cushing's disease were dispersed, and the isolated cells were grown in monolayer culture. Most of the cells showed ACTH immunoreactivity that persisted even after as much as 2 months in culture. Current clamp and voltage clamp recordings were carried out using the patch-clamp technique in the whole cell configuration. AVP produced an increase in the amplitude and duration of action potentials in these cells, and substantially enhanced the transient after-hyperpolarization after each spike. Under voltage clamp, hACTH adenoma cells showed two Ca2+ current components: a low-threshold, rapidly inactivating (T-type) current; and a higher threshold, slowly inactivating (L-type) current. AVP markedly increased the amplitude of the L-type current without affecting the T-type current. These data suggest that AVP may enhance Ca2+ entry associated with action potentials by potentiating the activity of L-type Ca2+ channels. The resulting rise in cytosolic free Ca2+ may be a key link in the process by which AVP stimulates ACTH release in the pituitary.",
author = "P. Mollard and P. Vacher and Rogawski, {Michael A} and B. Dufy",
year = "1988",
language = "English (US)",
volume = "2",
pages = "2907--2912",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "13",

}

TY - JOUR

T1 - Vasopressin enhances a calcium current in human ACTH-secreting pituitary adenoma cells

AU - Mollard, P.

AU - Vacher, P.

AU - Rogawski, Michael A

AU - Dufy, B.

PY - 1988

Y1 - 1988

N2 - Arginine vasopressin (AVP) is a potent secretagogue for adrenocorticotropin (ACTH) release from normal corticotropes and from ACTH-secreting pituitary adenoma cells. To explore the mechanism underlying this action, we investigated the effects of AVP on Ca2+-dependent action potentials and Ca2+ currents in cultured human ACTH-contaning pituitary tumor cells (hACTH adenoma cells). Pituitary adenoma fragments removed at surgery from two patients with Cushing's disease were dispersed, and the isolated cells were grown in monolayer culture. Most of the cells showed ACTH immunoreactivity that persisted even after as much as 2 months in culture. Current clamp and voltage clamp recordings were carried out using the patch-clamp technique in the whole cell configuration. AVP produced an increase in the amplitude and duration of action potentials in these cells, and substantially enhanced the transient after-hyperpolarization after each spike. Under voltage clamp, hACTH adenoma cells showed two Ca2+ current components: a low-threshold, rapidly inactivating (T-type) current; and a higher threshold, slowly inactivating (L-type) current. AVP markedly increased the amplitude of the L-type current without affecting the T-type current. These data suggest that AVP may enhance Ca2+ entry associated with action potentials by potentiating the activity of L-type Ca2+ channels. The resulting rise in cytosolic free Ca2+ may be a key link in the process by which AVP stimulates ACTH release in the pituitary.

AB - Arginine vasopressin (AVP) is a potent secretagogue for adrenocorticotropin (ACTH) release from normal corticotropes and from ACTH-secreting pituitary adenoma cells. To explore the mechanism underlying this action, we investigated the effects of AVP on Ca2+-dependent action potentials and Ca2+ currents in cultured human ACTH-contaning pituitary tumor cells (hACTH adenoma cells). Pituitary adenoma fragments removed at surgery from two patients with Cushing's disease were dispersed, and the isolated cells were grown in monolayer culture. Most of the cells showed ACTH immunoreactivity that persisted even after as much as 2 months in culture. Current clamp and voltage clamp recordings were carried out using the patch-clamp technique in the whole cell configuration. AVP produced an increase in the amplitude and duration of action potentials in these cells, and substantially enhanced the transient after-hyperpolarization after each spike. Under voltage clamp, hACTH adenoma cells showed two Ca2+ current components: a low-threshold, rapidly inactivating (T-type) current; and a higher threshold, slowly inactivating (L-type) current. AVP markedly increased the amplitude of the L-type current without affecting the T-type current. These data suggest that AVP may enhance Ca2+ entry associated with action potentials by potentiating the activity of L-type Ca2+ channels. The resulting rise in cytosolic free Ca2+ may be a key link in the process by which AVP stimulates ACTH release in the pituitary.

UR - http://www.scopus.com/inward/record.url?scp=0023731263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023731263&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 2907

EP - 2912

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 13

ER -